Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.26M | -10.70M | -10.42M | -10.16M | -10.03M |
| Total Depreciation and Amortization | 1.20M | 1.23M | 1.21M | 1.21M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 211.50K | 386.60K | 147.40K | 74.00K | -143.90K |
| Change in Net Operating Assets | -1.56M | -1.02M | -1.59M | -701.90K | 1.87M |
| Cash from Operations | -10.41M | -10.10M | -10.65M | -9.57M | -7.21M |
| Capital Expenditure | -190.60K | -173.60K | -221.40K | -221.40K | -54.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -181.80K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -190.60K | -173.60K | -221.40K | -221.40K | -235.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.30K |
| Issuance of Common Stock | 4.00M | 13.91M | 14.60M | 14.56M | 14.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | 3.04M | 3.04M | 3.04M |
| Repurchase of Preferred Stock | -- | -3.04M | -3.04M | -3.04M | -3.04M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 571.80K | 0.00 | 0.00 | -54.20K |
| Cash from Financing | 4.00M | 11.45M | 14.60M | 14.56M | 14.60M |
| Foreign Exchange rate Adjustments | 10.50K | -49.10K | 68.50K | -600.00 | -36.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.59M | 1.12M | 3.80M | 4.77M | 7.12M |